乳腺癌患者采用分子靶向治疗的临床研究(4)
[13] Baselga J，Segalla JG，Roche H，et al. Sorafenib in combination with capecitabine：an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer [J]. J Clin Oncol，2012，30(13)：1484-1491.[14] Mackey JR ......
您现在查看是摘要页，全文长 1841 字符。